CANCER

Genentech Advances Avastin Trial in Colon Cancer Patients

IBTimes Logo
Genentech Inc., the developer and maker of pharmaceutical products, said Thursday it expects final results from a clinical trial of a cancer drug Avastin in patients with colon cancer to be done by 2009, a year earlier than it previously forecasted.
More news
IBTimes Logo

Antisoma, Novartis drug fails in ovarian cancer

An experimental cancer drug from Britain's Antisoma Plc and Swiss-based Novartis AG has failed in a mid-stage clinical trial for ovarian cancer, lopping 15 percent off Antisoma's market value.

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.